HAAPALINNA ANTTI has a total of 12 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are NEUROLOGICAL TECHNOLOGIES INC, JOSHI YATINDRA and LANE HEIDI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Czechia | 1 | |
#6 | Estonia | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Norway | 1 | |
#9 | Poland | 1 | |
#10 | Slovakia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Haapalinna Antti | 12 |
#2 | Viitamaa Timo | 11 |
#3 | Sallinen Jukka | 10 |
#4 | Savola Juha-Matti | 10 |
#5 | Scheinin Mika | 10 |
#6 | Sirvioe Jouni | 1 |
#7 | Virtanen Raimo | 1 |
#8 | Juhila Juuso | 1 |
Publication | Filing date | Title |
---|---|---|
WO0239991A2 | Prevention of development of dyskinesias | |
CZ9903948A3 | Medicament for treating mammals suffering from mental disease induced by stress propagation | |
US5902807A | Method for the treatment of mental illness in mammals and a composition therefor |